Ozempic, Wegovy and other new drugs are selected for Medicare’s price negotiations
By AMANDA SEITZ
WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.
The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and almost assures billions of dollars in savings for taxpayers.
Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.
More Stories
Middle East war to drive 24% surge in energy costs – World Bank
The world is facing the biggest global energy supply shock on record, which will drive inflation and dampen economic growth...
US squares up to China over Panama Canal
Beijing has accused Washington of leading a smear campaign over its ownership of two ports The US has announced a...
Ukraine told to hike taxes to unlock Western aid – media
Both the EU and the IMF are reportedly making further funding conditional on specific fiscal reforms by Kiev Ukraine’s two...
Britain braces for £35bn energy shock as Iran conflict pushes inflation back above 4%
Britain’s small and medium-sized businesses are about to be marched back into the inflationary trenches they thought they had left...
Barclay Brothers swerve bankruptcy with eleventh-hour creditor pact
Aidan and Howard Barclay, the eldest sons of the late Sir David Barclay, have narrowly sidestepped bankruptcy after striking an...
John Lewis dragged into High Court over click-and-collect rent at Brent Cross
The John Lewis Partnership has been hauled before the High Court by the past and present owners of Brent Cross...